Published in Genome Res on February 27, 2009
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Chromatin remodelling during development. Nature (2010) 5.86
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Modification of enhancer chromatin: what, how, and why? Mol Cell (2013) 3.62
Medulloblastomics: the end of the beginning. Nat Rev Cancer (2012) 3.01
CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature (2010) 2.88
Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol (2011) 2.69
Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nat Genet (2011) 2.56
Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol (2011) 2.56
CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet (2010) 2.20
Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A (2010) 1.82
Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med (2012) 1.67
Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J Clin Invest (2009) 1.40
Discovery of active enhancers through bidirectional expression of short transcripts. Genome Biol (2011) 1.34
Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway. Mol Cell Biol (2011) 1.27
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos Trans R Soc Lond B Biol Sci (2013) 1.26
Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet (2009) 1.26
The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear. Development (2010) 1.24
Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders. Proc Natl Acad Sci U S A (2012) 1.15
CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis. Hum Mol Genet (2010) 1.13
Genetic syndromes caused by mutations in epigenetic genes. Hum Genet (2013) 1.11
Of mice and men: molecular genetics of congenital heart disease. Cell Mol Life Sci (2013) 1.10
The chromatin fingerprint of gene enhancer elements. J Biol Chem (2012) 1.08
Etiology of esophageal atresia and tracheoesophageal fistula: "mind the gap". Curr Gastroenterol Rep (2010) 1.07
Epigenetic virtues of chromodomains. Crit Rev Biochem Mol Biol (2011) 1.03
Role of canonical Wnt signaling/ß-catenin via Dermo1 in cranial dermal cell development. Development (2010) 1.03
Kismet/CHD7 regulates axon morphology, memory and locomotion in a Drosophila model of CHARGE syndrome. Hum Mol Genet (2010) 1.00
Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome. Elife (2013) 1.00
More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated. Mol Syndromol (2013) 1.00
Chromodomain proteins in development: lessons from CHARGE syndrome. Clin Genet (2010) 0.95
Transcription factor binding at enhancers: shaping a genomic regulatory landscape in flux. Front Genet (2012) 0.95
CHD chromatin remodelers and the transcription cycle. Transcription (2011) 0.94
MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness. Mamm Genome (2009) 0.93
An essential role of variant histone H3.3 for ectomesenchyme potential of the cranial neural crest. PLoS Genet (2012) 0.93
Epigenetic mechanisms in cardiac development and disease. Acta Biochim Biophys Sin (Shanghai) (2012) 0.93
Role of Chd7 in zebrafish: a model for CHARGE syndrome. PLoS One (2012) 0.92
ATP dependent chromatin remodeling enzymes in embryonic stem cells. Stem Cell Rev (2010) 0.92
The trithorax group protein Ash2l is essential for pluripotency and maintaining open chromatin in embryonic stem cells. J Biol Chem (2012) 0.90
Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice. Mech Dev (2012) 0.89
The epigenomics of embryonic stem cell differentiation. Int J Biol Sci (2013) 0.87
Chromatin and oxygen sensing in the context of JmjC histone demethylases. Biochem J (2014) 0.87
Twist1 mediates repression of chondrogenesis by β-catenin to promote cranial bone progenitor specification. Development (2012) 0.87
Transcription-coupled recruitment of human CHD1 and CHD2 influences chromatin accessibility and histone H3 and H3.3 occupancy at active chromatin regions. Epigenetics Chromatin (2015) 0.86
Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome. Trends Genet (2015) 0.86
CHD7 interacts with BMP R-SMADs to epigenetically regulate cardiogenesis in mice. Hum Mol Genet (2013) 0.84
Drug discovery toward antagonists of methyl-lysine binding proteins. Curr Chem Genomics (2011) 0.84
The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Mol Cell Endocrinol (2011) 0.83
Super Enhancers in Cancers, Complex Disease, and Developmental Disorders. Genes (Basel) (2015) 0.83
Otitis media in a new mouse model for CHARGE syndrome with a deletion in the Chd7 gene. PLoS One (2012) 0.83
Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes. Epigenomics (2014) 0.82
Identification and characterization of FAM124B as a novel component of a CHD7 and CHD8 containing complex. PLoS One (2012) 0.82
Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome. Dev Biol (2013) 0.81
Transcriptional regulation by trithorax-group proteins. Cold Spring Harb Perspect Biol (2014) 0.81
Structural pituitary abnormalities associated with CHARGE syndrome. J Clin Endocrinol Metab (2013) 0.80
Genomic characterization of the mouse ribosomal DNA locus. G3 (Bethesda) (2014) 0.80
Chromatin remodeling in development and disease: focus on CHD7. PLoS Genet (2010) 0.80
Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet (2015) 0.79
Epigenetic Developmental Disorders: CHARGE syndrome, a case study. Curr Genet Med Rep (2015) 0.79
Cloning and characterization of a novel alternatively spliced transcript of the human CHD7 putative helicase. BMC Res Notes (2010) 0.79
A critical role for the chromatin remodeller CHD7 in anterior mesoderm during cardiovascular development. Dev Biol (2015) 0.78
Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes. Hum Mol Genet (2015) 0.78
The chromatin Remodeler CHD8 is required for activation of progesterone receptor-dependent enhancers. PLoS Genet (2015) 0.78
CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions. Am J Hum Genet (2017) 0.78
Different CHD chromatin remodelers are required for expression of distinct gene sets and specific stages during development of Dictyostelium discoideum. Development (2013) 0.77
The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development. Dev Dyn (2014) 0.77
On the way of revealing coactivator complexes cross-talk during transcriptional activation. Cell Biosci (2016) 0.76
Enhancer deregulation in cancer and other diseases. Bioessays (2016) 0.76
Chromatin deregulation in disease. Chromosoma (2015) 0.76
A novel CHD7 mutation in a Chinese patient with CHARGE syndrome. Meta Gene (2014) 0.76
The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression. J Clin Invest (2017) 0.75
Harnessing Molecular Motors for Nanoscale Pulldown in Live Cells. Mol Biol Cell (2016) 0.75
Multi-layered global gene regulation in mouse embryonic stem cells. Cell Mol Life Sci (2014) 0.75
Rescue of neural crest-derived phenotypes in a zebrafish CHARGE model by Sox10 downregulation. Hum Mol Genet (2016) 0.75
Chromatin remodelers: We are the drivers!! Nucleus (2016) 0.75
Histone peptide microarray screen of chromo and Tudor domains defines new histone lysine methylation interactions. Epigenetics Chromatin (2017) 0.75
Mouse Models for the Dissection of CHD7 Functions in Eye Development and the Molecular Basis for Ocular Defects in CHARGE Syndrome. Invest Ophthalmol Vis Sci (2015) 0.75
Regulation of nucleosome positioning by a CHD Type III chromatin remodeler and its relationship to developmental gene expression in Dictyostelium. Genome Res (2017) 0.75
Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers: initial evidence of an oncogenic role for CHD7. Mol Oncol (2017) 0.75
Insights into inner ear-specific gene regulation: Epigenetics and non-coding RNAs in inner ear development and regeneration. Semin Cell Dev Biol (2016) 0.75
Versatile Roles of the Chromatin Remodeler CHD7 during Brain Development and Disease. Front Mol Neurosci (2017) 0.75
High-resolution profiling of histone methylations in the human genome. Cell (2007) 85.74
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A (2001) 68.44
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell (2008) 28.29
A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41
Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet (2008) 18.28
Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47
GENCODE: producing a reference annotation for ENCODE. Genome Biol (2006) 15.08
Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol (2005) 9.12
Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol (2003) 8.82
The "beta-like-globin" gene domain in human erythroid cells. Proc Natl Acad Sci U S A (1985) 8.35
Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet (2004) 6.90
A 200 base pair region at the 5' end of the chicken adult beta-globin gene is accessible to nuclease digestion. Cell (1981) 6.43
DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat Methods (2006) 6.25
Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome. PLoS Genet (2007) 5.93
Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol Cell (2007) 5.78
Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature (2005) 5.53
A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc Natl Acad Sci U S A (1986) 5.47
Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev (2002) 5.43
Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr (1981) 5.35
Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature (2005) 5.15
Locus control regions. Blood (2002) 4.41
Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression. Genome Res (2006) 4.32
Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J Biol Chem (2005) 4.20
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med (2007) 3.99
Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. Methods Enzymol (2006) 3.53
DNase I hypersensitive sites in Drosophila chromatin occur at the 5' ends of regions of transcription. Proc Natl Acad Sci U S A (1981) 3.39
CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) (1998) 3.33
An enhancer deletion affects both H19 and Igf2 expression. Genes Dev (1995) 3.09
A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res (2007) 2.97
Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol Cell (2002) 2.94
CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol Cell (2006) 2.93
Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem (2002) 2.89
Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta (2004) 2.86
CHD1 motor protein is required for deposition of histone variant H3.3 into chromatin in vivo. Science (2007) 2.71
Structured RNAs in the ENCODE selected regions of the human genome. Genome Res (2007) 2.69
Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet (2006) 2.62
Essential role for the SANT domain in the functioning of multiple chromatin remodeling enzymes. Mol Cell (2002) 2.33
Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet (2005) 2.22
CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes. Mol Cell Biol (2008) 2.10
A 1-megadalton ESC/E(Z) complex from Drosophila that contains polycomblike and RPD3. Mol Cell Biol (2003) 2.03
Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies. Nat Methods (2008) 2.02
The Drosophila trithorax group protein Kismet facilitates an early step in transcriptional elongation by RNA Polymerase II. Development (2005) 2.01
Location of enhancers is essential for the imprinting of H19 and Igf2 genes. Nature (1998) 1.88
Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. Proc Natl Acad Sci U S A (1992) 1.87
Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet (2005) 1.80
The Drosophila kismet gene is related to chromatin-remodeling factors and is required for both segmentation and segment identity. Development (1999) 1.77
Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet (2005) 1.71
Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome (2007) 1.58
CHARGE Association in newborns: a registry-based study. Teratology (1999) 1.55
Erythroid-specific nuclease-hypersensitive sites flanking the human beta-globin domain. Mol Cell Biol (1990) 1.54
Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr (2006) 1.45
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet (2006) 1.37
CHD8 associates with human Staf and contributes to efficient U6 RNA polymerase III transcription. Mol Cell Biol (2007) 1.20
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
High frequency of mutations of the PIK3CA gene in human cancers. Science (2004) 27.94
Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41
The accessible chromatin landscape of the human genome. Nature (2012) 16.86
High-resolution mapping and characterization of open chromatin across the genome. Cell (2008) 15.93
High-throughput oncogene mutation profiling in human cancer. Nat Genet (2007) 12.68
DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat Methods (2006) 6.25
DNase I sensitivity QTLs are a major determinant of human expression variation. Nature (2012) 6.17
The TetR family of transcriptional repressors. Microbiol Mol Biol Rev (2005) 6.02
Heritable individual-specific and allele-specific chromatin signatures in humans. Science (2010) 5.94
Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome. PLoS Genet (2007) 5.93
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
F-Seq: a feature density estimator for high-throughput sequence tags. Bioinformatics (2008) 4.77
High-resolution genome-wide in vivo footprinting of diverse transcription factors in human cells. Genome Res (2010) 4.69
PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A (2003) 4.46
Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res (2011) 4.43
An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol (2012) 4.15
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Res (2008) 4.08
Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res (2013) 3.61
Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res (2011) 3.57
DNase-seq: a high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harb Protoc (2010) 3.54
Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. Methods Enzymol (2006) 3.53
Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A (2014) 3.35
CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development (2009) 3.34
Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods (2013) 3.26
Biological features of novel avian influenza A (H7N9) virus. Nature (2013) 3.24
Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity (2010) 3.24
Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 2.90
4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys (2007) 2.80
Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function. Nat Cell Biol (2004) 2.63
Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet (2006) 2.62
Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm. Phys Med Biol (2007) 2.57
Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell (2013) 2.56
Dissecting the regulatory architecture of gene expression QTLs. Genome Biol (2012) 2.51
Study on nanometric cutting of germanium by molecular dynamics simulation. Nanoscale Res Lett (2013) 2.48
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res (2009) 2.32
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A (2008) 2.23
Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab (2010) 2.21
CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet (2010) 2.20
Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 2.16
Epigenomic enhancer profiling defines a signature of colon cancer. Science (2012) 2.15
Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res (2013) 2.14
Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol Cell Biol (2003) 2.12
Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration. Genome Res (2011) 2.07
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A (2010) 2.06
VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J Cell Biol (2002) 2.06
Structural insights into the activity of enhancer-binding proteins. Science (2005) 2.04
DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal (2010) 2.04
Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies. Nat Methods (2008) 2.02
A novel class of potent influenza virus inhibitors: polysubstituted acylthiourea and its fused heterocycle derivatives. Bioorg Med Chem Lett (2005) 2.01
Effects of sequence variation on differential allelic transcription factor occupancy and gene expression. Genome Res (2012) 1.99
The crystal structure of murine p97/VCP at 3.6A. J Struct Biol (2003) 1.98
p37 is a p97 adaptor required for Golgi and ER biogenesis in interphase and at the end of mitosis. Dev Cell (2006) 1.95
Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation. Proc Natl Acad Sci U S A (2002) 1.94
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 1.90
Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J Clin Endocrinol Metab (2005) 1.87
Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells. Nat Methods (2011) 1.85
Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A (2010) 1.82
Predicting cell-type-specific gene expression from regions of open chromatin. Genome Res (2012) 1.78
Gain of interaction with IRS1 by p110α-helical domain mutants is crucial for their oncogenic functions. Cancer Cell (2013) 1.74
Robust optimization of intensity modulated proton therapy. Med Phys (2012) 1.72
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res (2008) 1.70
RNA polymerase and transcription elongation factor Spt4/5 complex structure. Proc Natl Acad Sci U S A (2010) 1.70
Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions. Genome Res (2013) 1.69
Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J (2004) 1.68
Insights into adaptor binding to the AAA protein p97. Biochem Soc Trans (2008) 1.66
Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells. Carcinogenesis (2010) 1.64
Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.63
Going through the motions: the ATPase cycle of p97. J Struct Biol (2006) 1.61
Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys (2008) 1.56
Modus operandi of the bacterial RNA polymerase containing the sigma54 promoter-specificity factor. Mol Microbiol (2008) 1.56
Crystal structures of multidrug binding protein TtgR in complex with antibiotics and plant antimicrobials. J Mol Biol (2007) 1.55
Interferon regulatory factors are transcriptional regulators of adipogenesis. Cell Metab (2008) 1.55
Hadoop-GIS: A High Performance Spatial Data Warehousing System over MapReduce. Proceedings VLDB Endowment (2013) 1.55
Toward accurate high-throughput SNP genotyping in the presence of inherited copy number variation. BMC Genomics (2007) 1.54
Site-specific silencing of regulatory elements as a mechanism of X inactivation. Cell (2012) 1.54
Cell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells. Genome Res (2011) 1.53
Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet (2005) 1.52
Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys (2005) 1.49
Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J (2006) 1.48